DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cytarabine (Cytarabine) - Pneumonia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pneumonia (108)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 108   Next >>

Possible Cytarabine side effects in 44 year old male

Reported by a physician from Germany on 2012-08-17

Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-12

Etoposide
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-08

Gemtuzumab Ozogamicin
    Dosage: 6 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-06

Idarubicin HCL
    Dosage: 24 mg, daily
    Start date: 2012-06-08
    End date: 2012-06-08

Idarubicin HCL
    Dosage: 24 mg, daily
    Start date: 2012-06-10
    End date: 2012-06-10

Idarubicin HCL
    Dosage: 24 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-06

Tretinoin
    Dosage: 90 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-12

Tretinoin
    Dosage: 30 mg, daily
    Start date: 2012-06-13
    End date: 2012-06-16

Tretinoin
    Dosage: 30 mg, daily
    Start date: 2012-06-21
    End date: 2012-06-21



Possible Cytarabine side effects in 50 year old male

Reported by a physician from Germany on 2012-08-16

Patient: 50 year old male, weighing 73.0 kg (160.6 pounds)

Reactions: Neutropenic Colitis, Pneumonia

Drug(s) suspected as cause:
Atracurium Besylate
    Dosage: 90 mg, unk
    Start date: 2012-07-25

Cytarabine
    Dosage: 188 mg, unk
    Start date: 2012-07-19
    End date: 2012-07-24

Etoposide
    Dosage: 188 mg, unk
    Start date: 2012-07-19
    End date: 2012-07-21

Idarubicin HCL
    Dosage: 22.56 mg, unk
    Start date: 2012-07-19
    End date: 2012-07-24



Possible Cytarabine side effects in male

Reported by a physician from Germany on 2012-08-14

Patient: male, weighing 77.0 kg (169.4 pounds)

Reactions: Pulmonary Haemorrhage, White Blood Cell Count Decreased, Pneumonia, Hypotonia, Stenotrophomonas Infection, Blood Pressure Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 25 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-18
    End date: 2012-06-22

Cytarabine
    Dosage: 750 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-18
    End date: 2012-06-22

Idarubicin HCL
    Dosage: 12 mg/m2, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-18
    End date: 2012-06-20

Other drugs received by patient: Noxafil; Ambisome; Aciclovir-Ratiopharm; Clindamycin; Pantoprazole; Zienam; Piperacillin W



Possible Cytarabine side effects in male

Reported by a physician from Netherlands on 2012-08-09

Patient: male, weighing 75.0 kg (165.0 pounds)

Reactions: Pneumonia, Respiratory Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cytarabine
    Start date: 2012-06-15

Daunorubicin HCL
    Start date: 2012-06-15

Revlimid
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-29

Other drugs received by patient: Ciprofloxacin HCL; Temazepam; Lisinopril; Fluconazole; Colistin



Possible Cytarabine side effects in 50 year old male

Reported by a physician from Germany on 2012-08-07

Patient: 50 year old male

Reactions: Neutropenic Colitis, Pneumonia

Drug(s) suspected as cause:
Atracurium Besylate
    Dosage: 90 mg, unk
    Start date: 2012-07-25

Cytarabine
    Dosage: 188 mg, unk
    Start date: 2012-07-19
    End date: 2012-07-24

Etoposide
    Dosage: 188 mg, unk
    Start date: 2012-07-19
    End date: 2012-07-21

Idarubicin HCL
    Dosage: 22.56 mg, unk
    Start date: 2012-07-19
    End date: 2012-07-24



Possible Cytarabine side effects in 50 year old male

Reported by a physician from Germany on 2012-08-02

Patient: 50 year old male

Reactions: Neutropenic Colitis, Pneumonia

Drug(s) suspected as cause:
Atracurium Besylate
    Dosage: 90 mg, unk
    Start date: 2012-07-25

Cytarabine
    Dosage: 188 mg, unk
    Start date: 2012-07-19
    End date: 2012-07-24

Etoposide
    Dosage: 188 mg, unk
    Start date: 2012-07-19
    End date: 2012-07-21

Idarubicin HCL
    Dosage: 22.56 mg, unk
    Start date: 2012-07-19
    End date: 2012-07-24



Possible Cytarabine side effects in male

Reported by a physician from Netherlands on 2012-07-30

Patient: male, weighing 75.0 kg (165.0 pounds)

Reactions: Pneumonia, Respiratory Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cytarabine
    Start date: 2012-06-15

Daunorubicin HCL
    Start date: 2012-06-15

Revlimid
    Administration route: Oral
    Start date: 2012-06-15
    End date: 2012-06-29

Other drugs received by patient: Fluconazole; Ciprofloxacin HCL; Temazepam; Lisinopril; Colistin



Possible Cytarabine side effects in male

Reported by a physician from France on 2012-07-30

Patient: male, weighing 60.0 kg (132.0 pounds)

Reactions: Pneumonia, Intervertebral Discitis, Febrile Bone Marrow Aplasia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-15
    End date: 2012-04-22

Cytarabine
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-15
    End date: 2012-04-22

Dexamethasone
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-15
    End date: 2012-04-22

Mabthera
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-15
    End date: 2012-04-22

Other drugs received by patient: Clopidogrel



Possible Cytarabine side effects in female

Reported by a physician from France on 2012-07-25

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Pneumonia, Bone Marrow Failure

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 184 mg/cycle on 03/apr/2012
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-03

Cytarabine
    Dosage: 7.4 g/cycle between 03/apr/2012 and 04/apr/2012
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-03

Mabthera
    Dosage: 700 mg/cycle on 05/apr/2012 (normally on d4= 06/apr/2012 for cycle 1)
    Indication: Mantle Cell Lymphoma
    Start date: 2012-04-05

Other drugs received by patient: Eprex; Innohep



Possible Cytarabine side effects in 66 year old male

Reported by a physician from Japan on 2012-07-20

Patient: 66 year old male

Reactions: Pneumonia, Interstitial Lung Disease

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 40 mg/m2, unk
    Start date: 2010-12-22
    End date: 2010-12-22

Adriamycin PFS
    Dosage: 30 mg/m2, unk
    Start date: 2010-10-14
    End date: 2010-10-14

Adriamycin PFS
    Dosage: 30 mg/m2, unk
    Start date: 2010-11-24
    End date: 2010-11-24

Adriamycin PFS
    Dosage: 30 mg/m2, unk
    Start date: 2010-12-29
    End date: 2010-12-29

Adriamycin PFS
    Dosage: 40 mg/m2, unk
    Start date: 2010-11-16
    End date: 2010-11-16

Adriamycin PFS
    Dosage: 40 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-10-07

Allopurinol
    Dosage: 100 mg, 3x/day
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2011-07-19

Allopurinol
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Hyperuricaemia
    End date: 2011-01-20

Amlodipine
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-10-08
    End date: 2011-02-17

Baraclude
    Dosage: 0.5 mg, 1/2day
    Administration route: Oral
    Indication: Hepatitis B
    Start date: 2010-06-29
    End date: 2011-07-19

Carboplatin
    Dosage: 250 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-26
    End date: 2010-12-08

Cefazolin Sodium
    Dosage: unk
    Administration route: Oral
    Indication: Proctitis
    Start date: 2010-10-22
    End date: 2011-02-17

Cyclophosphamide
    Dosage: 350 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-12-22

Cymerin
    Dosage: 60 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-14
    End date: 2010-12-29

Cytarabine
    Dosage: 40 mg, daily
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-11-18
    End date: 2010-11-18

Diflucan
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    End date: 2011-01-11

Diflucan
    Dosage: unk
    Start date: 2011-01-19
    End date: 2011-01-28

Etoposide
    Dosage: 100 mg/m2, 3x/day
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-26
    End date: 2010-12-08

Fentanyl
    Dosage: unk
    Indication: Stomatitis
    Start date: 2011-01-02
    End date: 2011-01-19

Fildesin
    Dosage: 2.4 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-26
    End date: 2010-12-08

KW-0761
    Dosage: 1 mg/kg, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-08
    End date: 2010-12-21

Lansoprazole
    Dosage: 15 mg, 1x/day
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-07-19

Lansoprazole
    Dosage: 15 mg, 1x/day
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    End date: 2011-02-17

Lipidil
    Dosage: 100 df, 1x/day
    Administration route: Oral
    Indication: Hyperlipidaemia
    End date: 2011-01-26

Lyrica
    Dosage: 75 mg, 1x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-29
    End date: 2011-07-19

Magmitt
    Dosage: unk
    Administration route: Oral
    Indication: Constipation
    Start date: 2011-01-07
    End date: 2011-01-10

Meropenem
    Dosage: 0.5 g, 2x/day
    Indication: Pneumonia
    Start date: 2011-01-07
    End date: 2011-01-24

Meropenem
    Dosage: 1 g, 3x/day
    Start date: 2011-07-04
    End date: 2011-07-15

Methotrexate Sodium
    Dosage: 15 mg, daily
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-11-18
    End date: 2010-11-18

Oncovin
    Dosage: 1 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-12-22

Pantosin
    Dosage: unk
    Administration route: Oral
    Indication: Constipation
    Start date: 2011-01-07
    End date: 2011-01-10

Prednisolone
    Dosage: 40 mg/m2, unk
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-12-29

Prednisolone
    Dosage: 10 mg, daily
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-11-18
    End date: 2010-11-18

Sulfamethoxazole and Trimethoprim
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Start date: 2011-07-15

Sulfamethoxazole and Trimethoprim
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    End date: 2011-01-28

Vancomycin
    Dosage: 0.5 g, 2x/day
    Start date: 2011-01-07
    End date: 2011-01-17

Zovirax
    Dosage: unk
    Start date: 2011-06-30
    End date: 2011-07-08

Zovirax
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2011-01-28

Zovirax
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Start date: 2011-07-12
    End date: 2011-07-19

Other drugs received by patient: Vfend; Targocid; Slow-K; Ciprofloxacin HCL



Possible Cytarabine side effects in 44 year old male

Reported by a physician from Germany on 2012-07-19

Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-12

Etoposide
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-08

Gemtuzumab Ozogamicin
    Dosage: 6 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-06

Idarubicin HCL
    Dosage: 24 mg, daily
    Start date: 2012-06-08
    End date: 2012-06-08

Idarubicin HCL
    Dosage: 24 mg, daily
    Start date: 2012-06-10
    End date: 2012-06-10

Idarubicin HCL
    Dosage: 24 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-06

Tretinoin
    Dosage: 90 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-12

Tretinoin
    Dosage: 30 mg, daily
    Start date: 2012-06-13
    End date: 2012-06-16

Tretinoin
    Dosage: 30 mg, daily
    Start date: 2012-06-21
    End date: 2012-06-21



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-07-17

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Pneumonia, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10
    End date: 2012-05-12

Clofarabine
    Dosage: 19 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-11

Cytarabine
    Dosage: 3800 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-12

Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin



Possible Cytarabine side effects in 55 year old male

Reported by a physician from Austria on 2012-07-17

Patient: 55 year old male, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia, Colitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Atracurium Besylate
    Dosage: 90 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-04
    End date: 2012-06-06

Atracurium Besylate
    Dosage: 30 mg, 1x/day
    Start date: 2012-06-07

Cytarabine
    Dosage: 194 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-30
    End date: 2012-06-05

Etoposide
    Dosage: 190 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-30
    End date: 2012-06-01

Idarubicin HCL
    Dosage: 23 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-30
    End date: 2012-06-03

Other drugs received by patient: Vfend; Pantoprazole; Allopurinol; Meropenem



Possible Cytarabine side effects in

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient:

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carmustine
    Dosage: day - 7

Cytarabine
    Dosage: day -6 til day -3

Etoposide
    Dosage: day -6 till day -3

Melphalan Hydrochloride
    Dosage: day -2

Rituxan
    Dosage: day - 19 and day - 12

Velcade
    Dosage: d2 and d8
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-05-01

Vorinostat
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2012-04-30
    End date: 2012-05-06

Other drugs received by patient: Zovirax; Diphenhydramine HCL; Loperamide HCL; Dapsone; Compazine; Cholecalciferol; Allegra; Citalopram Hydrobromide; Bactrim; Potassium Chloride; Vitamin D (Unspecified); Potassium Bicarbonate; Nystatin; Lorazepam; Zofran; Folic Acid; Vitamins (Unspecified)



Possible Cytarabine side effects in 44 year old male

Reported by a physician from Germany on 2012-07-06

Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-12

Etoposide
    Dosage: 200 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-08

Gemtuzumab Ozogamicin
    Dosage: 6 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-06

Idarubicin HCL
    Dosage: 24 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-06
    End date: 2012-06-06

Idarubicin HCL
    Dosage: 24 mg, daily
    Start date: 2012-06-08
    End date: 2012-06-08

Idarubicin HCL
    Dosage: 24 mg, daily
    Start date: 2012-06-10
    End date: 2012-06-10

Tretinoin
    Dosage: 90 mg, daily
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-11
    End date: 2012-06-12

Tretinoin
    Dosage: 30 mg, daily
    Start date: 2012-06-21
    End date: 2012-06-21

Tretinoin
    Dosage: 30 mg, daily
    Start date: 2012-06-13
    End date: 2012-06-16



Possible Cytarabine side effects in male

Reported by a physician from Netherlands on 2012-07-06

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia, Leukoencephalopathy

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cellcept
    Dosage: last dose prior to sae: 24/mar/2012
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2012-02-10

Cisplatin
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-16

Cyclosporine
    Dosage: last dose prior to sae: 24/mar/2012
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2012-02-08

Cytarabine
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-17

Dexamethasone
    Dosage: last dose prior to sae: 19/dec/2011
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-16

Fludarabine Phosphate
    Dosage: date of last dose prior to sae: 08/feb/2012
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2012-02-06

Mabthera
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-16

Other drugs received by patient: Valacyclovir Hydrochloride; Anti-Thymocyte Globulin NOS; Cotrim; Prednisolone; Mitoxantrone; Prednisolone; Voriconazole; Posaconazole; Cotrim



Possible Cytarabine side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-04

Patient: 59 year old male

Reactions: Viral Infection, Pneumonia, Respiratory Failure, Acute Myeloid Leukaemia, Neutropenic Sepsis, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: continuous iv infusion for 7 days

Idarubicin HCL
    Dosage: 12 mg/m2/day for three days

Methylprednisolone
    Indication: Immunosuppression

Mycophenolate Mofetil
    Indication: Immunosuppression

Sirolimus

Tacrolimus
    Indication: Immunosuppression



Possible Cytarabine side effects in 55 year old male

Reported by a physician from Austria on 2012-07-02

Patient: 55 year old male, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia, Colitis

Adverse event resulted in: death

Drug(s) suspected as cause:
Atracurium Besylate
    Dosage: 30 mg, 1x/day
    Start date: 2012-06-07

Atracurium Besylate
    Dosage: 90 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-06-04
    End date: 2012-06-06

Cytarabine
    Dosage: 194 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-30
    End date: 2012-06-05

Etoposide
    Dosage: 190 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-30
    End date: 2012-06-01

Idarubicin HCL
    Dosage: 23 mg, 1x/day
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-30
    End date: 2012-06-03

Other drugs received by patient: Meropenem; Allopurinol; Vfend; Pantoprazole



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-02

Patient: male, weighing 98.5 kg (216.7 pounds)

Reactions: Pneumonia, Pyrexia, Neutropenia, Legionella Infection, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine



Possible Cytarabine side effects in female

Reported by a individual with unspecified qualification from United States on 2012-06-22

Patient: female, weighing 65.2 kg (143.4 pounds)

Reactions: Pneumonia, Febrile Neutropenia, Bone Marrow Failure, Escherichia Bacteraemia, Aspergillus Test Positive, Hydropneumothorax

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 40800 mg

Elspar
    Dosage: 20000 mg



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-06-19

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia, Respiratory Failure, Influenza

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10
    End date: 2012-05-12

Cytarabine
    Dosage: 1900 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-12

Evoltra
    Dosage: 19 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-11

Other drugs received by patient: Amphotericin B; Vancomycin; Meropenem



Possible Cytarabine side effects in male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-13

Patient: male

Reactions: Pneumonia, Interstitial Lung Disease, Hypotension, Chills, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Indication: Lymphoma
    Start date: 2010-09-03
    End date: 2010-09-03

Cytarabine
    Indication: Lymphoma
    Start date: 2010-09-03

Etoposide
    Indication: Lymphoma
    Start date: 2010-09-03
    End date: 2010-09-05

Gemcitabine Hydrochloride
    Indication: Lymphoma
    Start date: 2010-10-16
    End date: 2010-10-19

Gemcitabine Hydrochloride
    Start date: 2010-11-11
    End date: 2010-11-14

Ifosfamide
    Indication: Lymphoma
    Start date: 2010-10-16
    End date: 2010-10-19

Ifosfamide
    Start date: 2010-11-11
    End date: 2010-11-14

Mabthera
    Start date: 2010-05-07
    End date: 2010-11-10

Mabthera
    Dosage: vial 500 mg/50 ml
    Indication: Lymphoma
    Start date: 2010-05-07
    End date: 2010-10-05

Mabthera
    Dosage: vial 500 mg 50 ml
    End date: 2010-10-15

Methylprednisolone
    Start date: 2010-11-11
    End date: 2010-11-14

Methylprednisolone
    Indication: Lymphoma
    Start date: 2010-10-16
    End date: 2010-10-19

Vinorelbine
    Indication: Lymphoma
    Start date: 2010-10-19
    End date: 2010-10-20

Vinorelbine
    Start date: 2010-11-11
    End date: 2010-11-14



Possible Cytarabine side effects in male

Reported by a physician from Netherlands on 2012-06-13

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia, Leukoencephalopathy

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cellcept
    Dosage: last dose prior to sae: 24/mar/2012
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2012-02-10

Cisplatin
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-16

Cyclosporine
    Dosage: last dose prior to sae: 24/mar/2012
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2012-02-08

Cytarabine
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-17

Dexamethasone
    Dosage: last dose prior to sae: 19/dec/2011
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-16

Fludarabine Phosphate
    Dosage: date of last dose prior to sae: 08/feb/2012
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2012-02-06

Mabthera
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-16

Other drugs received by patient: Posaconazole; Voriconazole; Valacyclovir Hydrochloride; Cotrim; Cotrim



Possible Cytarabine side effects in female

Reported by a physician from Netherlands on 2012-06-12

Patient: female, weighing 73.0 kg (160.6 pounds)

Reactions: Pneumonia, Respiratory Failure, Influenza

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Amsacrine
    Dosage: 225 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-10
    End date: 2012-05-12

Clofarabine
    Dosage: 19 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-11

Cytarabine
    Dosage: 3800 mg, unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-07
    End date: 2012-05-12

Other drugs received by patient: Vancomycin HCL; Meropenem; Amphotericin B



Possible Cytarabine side effects in male

Reported by a physician from United States on 2012-06-12

Patient: male, weighing 109.0 kg (239.8 pounds)

Reactions: Mucosal Inflammation, Pneumonia, Febrile Neutropenia, Bacterial Sepsis, Acute Respiratory Distress Syndrome, Necrotising Fasciitis, Septic Shock, Full Blood Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 70 mg

Daunorubicin HCL
    Dosage: 70 mg

Methotrexate
    Dosage: 15 mg

Methylprednisolone
    Dosage: 70 mg

PEG-L-Asparaginase (K-H)
    Dosage: 5500 mg

Vincristine Sulfate
    Dosage: 8 mg



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-06-06

Patient: female, weighing 21.4 kg (47.1 pounds)

Reactions: Pneumonia, Cardiac Murmur, Tachycardia, Pancytopenia, Endocarditis, Tricuspid Valve Incompetence, Staphylococcal Bacteraemia, Septic Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 30 mg
    End date: 2012-04-23

Mitoxantrone Hydrochloride
    Dosage: 16.4 mg
    End date: 2012-04-26

Tretinoin
    Dosage: 280 mg
    End date: 2012-05-07



Possible Cytarabine side effects in male

Reported by a individual with unspecified qualification from Netherlands on 2012-06-01

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Pneumonia, Leukoencephalopathy

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cellcept
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2012-02-10

Cisplatin
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-16

Cyclosporine
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2012-02-08

Cytarabine
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-17

Dexamethasone
    Dosage: last dose prior to sae 19/dec/2011
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-16

Fludarabine Phosphate
    Dosage: date of last dose prior to sae: 08/feb/2012
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2012-02-06

Mabthera
    Indication: Chronic Lymphocytic Leukaemia Refractory
    Start date: 2011-12-16

Other drugs received by patient: Posaconazole; Cotrim; Valacyclovir Hydrochloride; Cotrim; Voriconazole



Possible Cytarabine side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-30

Patient: 49 year old female

Reactions: Multi-Organ Failure, Lymphocytosis, Acute Lymphocytic Leukaemia, Refractory Anaemia, Pneumonia, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 100 mg
    Administration route: Oral
    Indication: Anaemia

Cyclophosphamide
    Indication: Breast Cancer

Cyclophosphamide
    Indication: Leukocytosis
    Start date: 2009-07-01

Cyclophosphamide
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Dexamethasone
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Doxorubicin HCL
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Methotrexate
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01

Prednisolone
    Indication: Leukocytosis

Prednisolone
    Dosage: 15 mg
    Indication: Anaemia

Vincristine
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-07-01



Possible Cytarabine side effects in 49 year old female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-28

Patient: 49 year old female

Reactions: Pneumonia, B Precursor Type Acute Leukaemia

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer

Cytarabine
    Indication: Breast Cancer

Dexamethasone
    Indication: Breast Cancer

Doxorubicin HCL
    Indication: Breast Cancer

Epirubicin
    Indication: Breast Cancer

Fluorouracil
    Indication: Breast Cancer

Methotrexate
    Indication: Breast Cancer

Vincristine
    Indication: Breast Cancer



Possible Cytarabine side effects in female

Reported by a physician from United States on 2012-05-24

Patient: female, weighing 21.4 kg (47.1 pounds)

Reactions: Streptococcal Bacteraemia, Pneumonia, Tachycardia, Pancytopenia, Endocarditis, Tricuspid Valve Incompetence, Septic Shock

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cytarabine
    Dosage: 30 mg
    End date: 2012-04-23

Mitoxantrone Hydrochloride
    Dosage: 16.4 mg
    End date: 2012-04-26

Tretinoin
    Dosage: 280 mg
    End date: 2012-05-07



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014